These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 27376790)

  • 1. Birch pollen immunotherapy inhibits anaphylaxis to the cross-reactive apple allergen Mal d 1 in mice.
    Utsch L; Logiantara A; Wallner M; Hofer H; van Ree R; van Rijt LS
    Clin Exp Allergy; 2016 Nov; 46(11):1474-1483. PubMed ID: 27376790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoblotting in the diagnosis of cross-reactivity in children allergic to birch.
    Cudowska B; Kaczmarski M; Restani P
    Rocz Akad Med Bialymst; 2005; 50():268-73. PubMed ID: 16358981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergy.
    Sánchez Acosta G; Kinaciyan T; Kitzmüller C; Möbs C; Pfützner W; Bohle B
    J Allergy Clin Immunol; 2020 Oct; 146(4):894-900.e2. PubMed ID: 32259540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
    Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B
    J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
    Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
    Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous apple consumption induces oral tolerance in birch-pollen-associated apple allergy.
    Kopac P; Rudin M; Gentinetta T; Gerber R; Pichler Ch; Hausmann O; Schnyder B; Pichler WJ
    Allergy; 2012 Feb; 67(2):280-5. PubMed ID: 22070352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birch-apple syndrome treated with birch pollen immunotherapy.
    Mauro M; Russello M; Incorvaia C; Gazzola G; Frati F; Moingeon P; Passalacqua G
    Int Arch Allergy Immunol; 2011; 156(4):416-22. PubMed ID: 21832831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergen immunotherapy for birch-apple syndrome: what do we know?
    Incorvaia C; Ridolo E; Mauro M; Russello M; Pastorello E
    Immunotherapy; 2017 Nov; 9(15):1271-1278. PubMed ID: 29130794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pollen-related food allergy: cloning and immunological analysis of isoforms and mutants of Mal d 1, the major apple allergen, and Bet v 1, the major birch pollen allergen.
    Son DY; Scheurer S; Hoffmann A; Haustein D; Vieths S
    Eur J Nutr; 1999 Aug; 38(4):201-15. PubMed ID: 10502033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy.
    Kinaciyan T; Nagl B; Faustmann S; Frommlet F; Kopp S; Wolkersdorfer M; Wöhrl S; Bastl K; Huber H; Berger U; Bohle B
    J Allergy Clin Immunol; 2018 Mar; 141(3):1002-1008. PubMed ID: 28870463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Mal d 1 facilitates sublingual challenge tests of birch pollen-allergic patients with apple allergy.
    Kinaciyan T; Nagl B; Faustmann S; Kopp S; Wolkersdorfer M; Bohle B
    Allergy; 2016 Feb; 71(2):272-4. PubMed ID: 26443126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High correlation of specific IgE sensitization between birch pollen, soy and apple allergens indicates pollen-food allergy syndrome among birch pollen allergic patients in northern China.
    Hao GD; Zheng YW; Wang ZX; Kong XA; Song ZJ; Lai XX; Spangfort MD
    J Zhejiang Univ Sci B; 2016 May; 17(5):399-404. PubMed ID: 27143268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Birch Pollen Immunotherapy on Apple and rMal d 1 Challenges in Adults with Apple Allergy.
    van der Valk JPM; Nagl B; van Wljk RG; Bohle B; de Jong NW
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32085633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bet v 1, the major birch pollen allergen, and Mal d 1, the major apple allergen, cross-react at the level of allergen-specific T helper cells.
    Fritsch R; Bohle B; Vollmann U; Wiedermann U; Jahn-Schmid B; Krebitz M; Breiteneder H; Kraft D; Ebner C
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):679-86. PubMed ID: 9802379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food allergy to apple and specific immunotherapy with birch pollen.
    Hansen KS; Khinchi MS; Skov PS; Bindslev-Jensen C; Poulsen LK; Malling HJ
    Mol Nutr Food Res; 2004 Nov; 48(6):441-8. PubMed ID: 15508179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cor a 1-reactive T cells and IgE are predominantly cross-reactive to Bet v 1 in patients with birch pollen-associated food allergy to hazelnut.
    Hofmann C; Scheurer S; Rost K; Graulich E; Jamin A; Foetisch K; Saloga J; Vieths S; Steinbrink K; Adler HS
    J Allergy Clin Immunol; 2013 May; 131(5):1384-92.e6. PubMed ID: 23246018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergy to apple cultivars among patients with birch pollinosis and oral allergy syndrome.
    Wagner A; Szwed A; Buczyłko K; Wagner W
    Ann Allergy Asthma Immunol; 2016 Oct; 117(4):399-404. PubMed ID: 27593099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization profiles in birch pollen-allergic patients with and without oral allergy syndrome to apple: lessons from multiplexed component-resolved allergy diagnosis.
    Ebo DG; Bridts CH; Verweij MM; De Knop KJ; Hagendorens MM; De Clerck LS; Stevens WJ
    Clin Exp Allergy; 2010 Feb; 40(2):339-47. PubMed ID: 19709127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe oral allergy syndrome and anaphylactic reactions caused by a Bet v 1- related PR-10 protein in soybean, SAM22.
    Kleine-Tebbe J; Vogel L; Crowell DN; Haustein UF; Vieths S
    J Allergy Clin Immunol; 2002 Nov; 110(5):797-804. PubMed ID: 12417891
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Aglas L; Bethanis A; Chrusciel P; Stolz F; Gruen M; Jaakkola UM; Jongejan L; Yatkin E; Van Ree R
    Front Immunol; 2020; 11():2118. PubMed ID: 33013894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.